Submitted:
06 September 2023
Posted:
06 September 2023
You are already at the latest version
Abstract
Keywords:
Introduction
Materials and methods
Study population
CMR data acquisition and ventricular function analysis
Echocardiography image acquisition
Inter-ventricular mechanical dyssynchrony analysis
4D flow components and kinetic energy
Intra- and inter-observer variability
Statistical analysis
Results
Participant characteristics and ventricular function
Changes in 4D flow components, kinetic energy and inter-ventricular mechanical dyssynchrony profiles


Association of 4D flow parameters with LVdiastolic dysfunction
Disruption of intracardiac flow in rFontan groups with morphologic LV or RV
Intra and inter-observer variability
Discussion
The characteristics of intracardiac flow components
The function of KE in rFontan patients
Assessment of diastolic dysfunction in rFontan group
Intracardiac flow in single ventricle physiology
Limitations
Conclusions
Supplementary Materials
Acknowledgements
Abbreviations
| 4D | Four-dimensional |
| 2D b-SSFP | 2D balanced steady state free precession |
| AUC | Area under curve |
| BSA | Body surface area |
| CI | Cardiac index |
| CMR | Cardiovascular magnetic resonance |
| CO | Cardiac output |
| COV | Coefficient of variation |
| DCM | Dilated cardiomyopathy |
| ED | End diastole |
| EDV | End-diastolic volume |
| EF | Ejection fraction |
| EL | Energy loss |
| ES | End systole |
| ESV | End-systolic volume |
| FSV | Functional single ventricle |
| ICC | Intraclass correlation coefficient |
| KE | Kinetic energy |
| KEiEDV | KE indexed to the ventricular end-diastolic volume |
| LV | Left ventricle |
| LGE | Late gadolinium enhancement |
| rFontan | Repaired Fontan |
| ROC | Receiver operator characteristic |
| RV | Right ventricle |
| SD | Standard deviation |
| SV | Stroke volume |
| T-Dmax | Time to maximal displacement |
References
- Tseng SY, Siddiqui S, Di Maria MV et al (2020) Atrioventricular valve regurgitation in single ventricle heart disease: a common problem associated with progressive deterioration and mortality. J Am Heart Assoc 9:e015737. [CrossRef]
- Kato A, Riesenkampff E, Yim D, Yoo SJ, Seed M, Grosse-Wortmann L (2017) Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction. Int J Cardiol 240:172–177. [CrossRef]
- Logoteta J, Ruppel C, Hansen JH et al (2017) Ventricular function and ventriculo-arterial coupling after palliation of hypoplastic left heart syndrome: A comparative study with Fontan patients with LV morphology. Int J Cardiol 227:691-697. [CrossRef]
- Budts W, Ravekes WJ, Danford DA, Kutty S (2020) Diastolic Heart failure in patients with the Fontan circulation: A Review. JAMA Cardiol 5:590-597. [CrossRef]
- Gupta Aakash N, Markl Michael, Elbaz Mohammed S M, Intracardiac and Vascular Hemodynamics with Cardiovascular Magnetic Resonance in Heart Failure.[J] .Heart Fail Clin, 2021, 17: 135-147. [CrossRef]
- Soulat G, McCarthy P, Markl M (2020) 4D flow with MRI. Annu Rev Biomed Eng 22:103-126. [CrossRef]
- Garcia J, Barker AJ, Markl M (2019) The role of imaging of flow patterns by 4D flow MRI in aortic stenosis. JACC Cardiovasc Imaging 12:252-266.
- Crandon S, Elbaz MSM, Westenberg JJM, van der Geest RJ, Plein S, Garg P (2017) Clinical applications of intra-cardiac four-dimensional flow cardiovascular magnetic resonance: a systematic review. Int J Cardiol 249:486-493. [CrossRef]
- Zhong L, Schrauben EM, Garcia J et al (2019) Intracardiac 4D flow CMR in congenital heart disease: recommendations on behalf of the ISMRM Flow & Motion Study Group. J Magn Reson Imaging 50:677-681. [CrossRef]
- Wong J, Chabiniok R, Tibby SM et al (2018) Exploring kinetic energy as a new marker of cardiac function in the single ventricle circulation. J Appl Physiol 125:889-900. [CrossRef]
- Kamphuis VP, Elbaz MSM, van den Boogaard PJ et al (2019) Stress increases intracardiac 4D flow cardiovascular magnetic resonance -derived energetics and vorticity and relates to VO2max in Fontan patients. J Cardiovasc Magn Reson 21:43. [CrossRef]
- Sjöberg P, Heiberg E, Wingren P et al (2017) Decreased diastolic ventricular kinetic energy in young patients with Fontan circulation demonstrated by four-dimensional cardiac magnetic resonance imaging. Pediatr Cardiol 38:669-680.
- Rutkowski DR, Barton G, François CJ, Bartlett HL, Anagnostopoulos PV, Roldán-Alzate A (2019) Analysis of cavopulmonary and cardiac flow characteristics in fontan patients: comparison with healthy volunteers. J Magn Reson Imaging 49:1786-1799. [CrossRef]
- Hu Liwei,Sun Aimin,Guo Chen et al. Assessment of global and regional strain left ventricular in patients with preserved ejection fraction after Fontan operation using a tissue tracking technique.[J] .Int J Cardiovasc Imaging, 2019, 35: 153-160. [CrossRef]
- Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277–314. [CrossRef]
- Leng S, Zhao XD, Huang FQ et al (2015) Automated quantitative assessment of cardiovascular magnetic resonance-derived atrioventricular junction velocities. Am J Physiol Heart Circ Physiol 309:1923-1935. [CrossRef]
- Klein S, Staring M, Murphy K, Viergever MA, Pluim JP (2010) elastix: a toolbox for intensity-based medical image registration.[J]. IEEE Trans Med Imaging 29:196–205. [CrossRef]
- Stoll VM, Hess AT, Rodgers CT et al (2019) Left ventricular flow analysis. Circ Cardiovasc Imaging 12:e008130.
- Eriksson J, Bolger AF, Ebbers T, Carlhäll CJ (2013) Four-dimensional blood flow-specific markers of LV dysfunction in dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 14:417–424. [CrossRef]
- Eriksson J, Dyverfeldt P, Engvall J, Bolger AF, Ebbers T, Carlhäll CJ (2011) Quantification of presystolic blood flow organization and energetics in the human left ventricle. Am J Physiol Heart Circ Physiol 300:H2135-41. [CrossRef]
- Stone ML, Schäfer M, DiMaria MV et al (2022) Diastolic inflow is associated with inefficient ventricular flow dynamics in Fontan patients. J Thorac Cardiovasc Surg 163:1195-1207. [CrossRef]
- Bolger AF, Heiberg E, Karlsson M et al (2007) Transit of blood flow through the human left ventricle mapped by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 9:741-7. [CrossRef]
- Kamphuis VP, Elbaz MSM, van den Boogaard PJ et al (2013) Disproportionate intraventricular viscous energy loss in Fontan patients: analysis by 4D flow MRI. Eur Heart J Cardiovasc Imaging 20:323-333. [CrossRef]
- Zhao X, Hu L, Leng S et al (2022) Ventricular flow analysis and its association with exertional capacity in repaired tetralogy of Fallot: 4D flow cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 24:4. [CrossRef]
- Kato Atsuko,Riesenkampff Eugénie,Yim Deane et al (2017) Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction.Int J Cardiol, 240: 172-177. [CrossRef]
- Bharucha T, Khan R, Mertens L, Friedberg MK (2013) Right ventricular mechanical dyssynchrony and asymmetric contraction in hypoplastic heart syndrome are associated with tricuspid regurgitation. J Am Soc Echocardiogr 26:1214-1220. [CrossRef]
- Zaidi SJ, Penk J, Cui VW, Roberson DA (2019) Right ventricular mechanical dyssynchrony in hypoplastic left heart syndrome: correlation with systolic function and QRS duration. Pediatr Cardiol 40:934-942. [CrossRef]
- Gokhale J, Husain N, Nicholson L, Texter KM, Zaidi AN, Cua CL (2013) QRS duration and mechanical dyssynchrony correlations with right ventricular function after fontan procedure. J Am Soc Echocardiogr 26:154-9. [CrossRef]
- Rösner A, Khalapyan T, Dalen H, McElhinney DB, Friedberg MK, Lui GK (2018) Classic-pattern dyssynchrony in adolescents and adults with a Fontan circulation. J Am Soc Echocardiogr 31:211-219. [CrossRef]
- Kanski M, Töger J, Steding-Ehrenborg K et al (2015) Whole-heart four-dimensional flow can be acquired with preserved quality without respiratory gating, facilitating clinical use: a head-to-head comparison. BMC Med Imaging 15:20. [CrossRef]



| Parameters | Control (n=14) | rFontan (n=25) | P |
|---|---|---|---|
| Demographics | |||
| Age, years | 10 (9, 11) | 9 (8, 12) | 0.836 |
| Follow-up time since surgery, years | - | 5 (3, 7) | - |
| Gender, M/F | 8/6 (57%) | 15/10 (60%) | 0.866 |
| Height, cm | 144 (132, 150) | 125 (120, 135) | 0.039 |
| Weight, kg | 37 (28, 45) | 25 (20, 31) | 0.008 |
| Body surface area, m2 | 1.22 (1.02,1.37) | 0.93 (0.82, 1.05) | 0.012 |
| Systolic blood pressure, mmHg | 114 (109,118) | 112 (107,116) | 0.624 |
| Diastolic blood pressure, mmHg | 69 (65,73) | 66 (61,71) | 0.228 |
| Heart rate, bpm | 77 (71, 87) | 79 (62, 93) | 0.745 |
| Mass index, g/m2 | 38 (35, 40) | 37 (29, 46) | 0.588 |
| EDV index, ml/m2 | 73 (64, 86) | 80 (57, 100) | 0.671 |
| ESV index, ml/m2 | 31 (29, 35) | 38 (27, 44) | 0.151 |
| SV index, ml/m2 | 39 (35, 52) | 41 (30, 57) | 0.580 |
| Ejection fraction, % | 58 (56, 60) | 56 (51, 63) | 0.142 |
| Cardiac output, L/min | 3.64 (3.21, 4.14) | 3.21 (2.65, 3.72) | 0.298 |
| Cardiac output index, L/min/m2 | 4.05 (3.32, 4.76) | 3.39 (2.19, 4.27) | 0.271 |
| E-wave velocities, cm/s | - | 79.68(56.7,96.5) | - |
| A-wave velocities, cm/s | - | 58.28(43.2,76) | - |
| E/A ratio | - | 1.54(1,2.05) | - |
| LV Diastolic dysfunction, n | 0 (%) | 9/16* (56%) | - |
| Blood flow components | |||
| Direct flow, % | 40 (37, 41) | 32 (28, 39) | 0.005 |
| Retained inflow, % | 12 (10, 16) | 18 (12, 24) | 0.072 |
| Delayed ejection flow, % | 24 (19, 27) | 17 (13, 23) | 0.024 |
| Residual volume, % | 23 (18, 29) | 28 (24, 35) | 0.034 |
| Kinetic energy (KE) indexed to EDV | |||
| Average KEiEDV, µJ/ml | 11.2 (9.8, 14.3) | 6.6 (4.6, 8.1) | <0.001 |
| Peak systolic KEiEDV, µJ/ml | 23.5 (20.7, 27.5) | 11.7 (9.4, 16.3) | <0.001 |
| Systolic KEiEDV, µJ/ml | 11.7 (9.6, 15.6) | 6.7 (4.7, 8.4) | <0.001 |
| Diastolic KEiEDV, µJ/ml | 11.8 (8.6, 14.5) | 6.5 (4.3, 8.6) | <0.001 |
| Peak E-wave KEiEDV, µJ/ml | 27.5 (23.6, 31.7) | 11.7 (9.1, 15.3) | <0.001 |
| Peak A-wave KEiEDV, µJ/ml | 12.1 (9.8, 13.7) | 8.3 (4.8, 10.9) | 0.019 |
| KEiEDV E/A ratio | 2.38 (1.92, 2.71) | 1.44 (1.07, 2.48) | 0.02 |
| Parameters | Control (n=14) | rFontan (n=25) | P |
|---|---|---|---|
| Basal KE indexed to EDV | |||
| Average KEiEDV, µJ/ml | 7.5 (6.5, 8.9) | 4.3 (3.3, 5.4) | <0.001 |
| Peak systolic KEiEDV, µJ/ml | 16.0 (12.5, 18.0) | 9.4 (6.6, 10.9) | <0.001 |
| Systolic KEiEDV, µJ/ml | 8.9 (6.1, 8.9) | 4.2 (3.5, 5.4) | <0.001 |
| Diastolic KEiEDV, µJ/ml | 7.2 (6.3, 8.8) | 3.6 (2.5, 5.3) | <0.001 |
| Peak E-wave KEiEDV, µJ/ml | 18.5 (15.9, 20.3) | 8.0 (6.1, 10.3) | <0.001 |
| Peak A-wave KEiEDV, µJ/ml | 7.2 (5.6, 7.8) | 4.7 (2.9, 7.3) | 0.100 |
| KEiEDV E/A ratio | 2.72 (1.94, 3.45) | 1.70 (1.13, 2.57) | 0.006 |
| Mid KE indexed to EDV | |||
| Average KEiEDV, µJ/ml | 3.3 (2.9, 4.0) | 1.6 (1.2, 2.4) | <0.001 |
| Peak systolic KEiEDV, µJ/ml | 4.8 (3.8, 5.7) | 2.8 (1.8, 3.6) | <0.001 |
| Systolic KEiEDV, µJ/ml | 2.7 (2.5, 3.3) | 1.7 (1.1, 2.1) | 0.001 |
| Diastolic KEiEDV, µJ/ml | 4.1 (3.2, 4.7) | 1.7 (1.3, 2.7) | <0.001 |
| Peak E-wave KEiEDV, µJ/ml | 8.3 (6.6, 11.2) | 3.2 (2.3, 4.2) | <0.001 |
| Peak A-wave KEiEDV, µJ/ml | 3.9 (3.2, 5.1) | 2.4 (1.4, 3.1) | 0.002 |
| KEiEDV E/A ratio | 2.11 (1.57, 3.12) | 1.28 (1.03, 2.33) | 0.021 |
| Apical KE indexed to EDV | |||
| Average KEiEDV, µJ/ml | 0.8 (0.6, 1.3) | 0.2 (0.2, 0.4) | <0.001 |
| Peak systolic KEiEDV, µJ/ml | 1.5 (1.3, 1.9) | 0.5 (0.3, 0.7) | <0.001 |
| Systolic KEiEDV, µJ/ml | 0.8 (0.7, 1.0) | 0.3 (0.2, 0.4) | <0.001 |
| Diastolic KEiEDV, µJ/ml | 0.7 (0.6, 1.3) | 0.3 (0.1, 0.4) | <0.001 |
| Peak E-wave KEiEDV, µJ/ml | 1.3 (0.8, 1.9) | 0.4 (0.2, 0.7) | <0.001 |
| Peak A-wave KEiEDV, µJ/ml | 1.3 (1.0, 1.9) | 0.3 (0.2, 0.5) | <0.001 |
| KEiEDV E/A ratio | 0.84 (0.63, 1.23) | 1.16 (0.87, 2.05) | 0.037 |
| 4D flow parameters | rFontan with inter-ventricular mechanical dyssynchrony (n=15)* | rFontan without inter-ventricular mechanical dyssynchrony (n=9) | P |
|---|---|---|---|
| Blood flow components | |||
| Direct flow, % | 34 (29, 39) | 29 (25, 37) | 0.272 |
| Retained inflow, % | 18 (17, 21) | 12 (8, 25) | 0.814 |
| Delayed ejection flow, % | 17 (12, 23) | 17 (14, 23) | 0.859 |
| Residual volume, % | 27 (24, 32) | 33 (27, 40) | 0.162 |
| Kinetic energy (KE) indexed to EDV | |||
| Average KEiEDV, µJ/ml | 7.0 (5.0,9.7) | 6.3 (4.4, 8.1) | 0.682 |
| Peak systolic KEiEDV, µJ/ml | 11.3 (9.9, 15.1) | 13.4 (10.4, 19.4) | 0.347 |
| Systolic KEiEDV, µJ/ml | 6.7 (5.2, 7.5) | 7.1 (4.7, 9.7) | 0.861 |
| Diastolic KEiEDV, µJ/ml | 7.8 (4.6, 9.3) | 5.3 (4.0, 6.8) | 0.181 |
| Peak E-wave KEiEDV, µJ/ml | 14.0 (9.2, 16.7) | 11.2 (9.0, 12.1) | 0.131 |
| Peak A-wave KEiEDV, µJ/ml | 9.8 (4.6, 13.9) | 7.3 (5.7, 10.7) | 0.432 |
| KEiEDV E/A ratio | 1.44 (1.01, 2.66) | 1.38 (1.11, 2.06) | 0.788 |
| Parameters | rFontan with diastolic dysfunction (n=9) | rFontan without diastolic dysfunction (n=7) | P |
|---|---|---|---|
| Blood flow components | |||
| Direct flow, % | 30 (26, 34) | 38 (31, 42) | 0.031 |
| Retained inflow, % | 19 (12, 24) | 17 (12, 22) | 0.807 |
| Delayed ejection flow, % | 17 (13, 23) | 17 (12, 21) | 0.605 |
| Residual volume, % | 29 (25, 40) | 26 (24, 31) | 0.216 |
| Kinetic energy (KE) indexed to EDV | |||
| Average KEiEDV, µJ/ml | 6.6 (4.8, 8.8) | 6.2 (3.8, 7.7) | 0.428 |
| Peak systolic KEiEDV, µJ/ml | 13.1 (10.0, 17.1) | 10.9 (8.5, 13.3) | 0.160 |
| Systolic KEiEDV, µJ/ml | 7.1 (5.4, 10.0) | 5.8 (3.8, 7.5) | 0.144 |
| Diastolic KEiEDV, µJ/ml | 6.3 (4.6, 9.3) | 7.1 (3.7, 8.6) | 0.978 |
| Peak E-wave KEiEDV, µJ/ml | 11.2 (9.1, 15.2) | 11.9 (8.6, 15.8) | 0.892 |
| Peak A-wave KEiEDV, µJ/ml | 8.1 (5.2, 10.3) | 10.1 (2.5, 12.2) | 0.935 |
| KEiEDV E/A ratio | 1.49 (1.01, 2.03) | 1.44 (1.08, 2.91) | 0.683 |
| Parameters | rFontan (n=18) | P | |
|---|---|---|---|
| Morphologic LV (n=9) | Morphologic RV (n=9) | ||
| Blood flow components | |||
| Direct flow, % | 33 (28, 38) | 29 (25, 39) | 0.511 |
| Retained inflow, % | 18 (12, 24) | 17 (10, 24) | 0.948 |
| Delayed ejection flow, % | 21 (15, 24) | 15 (12, 21) | 0.435 |
| Residual volume, % | 24 (23, 31) | 33 (29, 40) | 0.020 |
| Kinetic energy (KE) indexed to EDV | |||
| Average KEiEDV, µJ/ml | 6.6 (4.7, 8.7) | 6.1 (4, 7.8) | 0.347 |
| Peak systolic KEiEDV, µJ/ml | 11.3 (9.9, 14.5) | 11.6 (8.2, 14.03) | 0.605 |
| Systolic KEiEDV, µJ/ml | 6.8 (5.4, 7.5) | 6.3 (4.2, 8.5) | 0.431 |
| Diastolic KEiEDV, µJ/ml | 6.3 (4.3, 9.6) | 5.1 (3.5, 8.2) | 0.351 |
| Peak E-wave KEiEDV, µJ/ml | 12.4 (8.9, 17.7) | 11.2 (9.1, 14.1) | 0.002 |
| Peak A-wave KEiEDV, µJ/ml | 8.3 (4.6, 12.6) | 6.6 (3.8, 10.3) | 0.369 |
| KEiEDV E/A ratio | 1.62 (1.04, 2.41) | 1.44 (1.34, 2.54) | 0.880 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).